glp-1 weight loss telehealth MEDVi is showing what a new kind of company can look like A platform selling weight-loss drugs directly to consumers Built in ~2 months with ~20K Now tracking toward $1.8B Risk of all–cause death single Size:One Pack

glp-1 weight loss telehealth MEDVi is showing what a new kind of company can look like A platform selling weight-loss drugs directly to consumers Built in ~2 months with ~20K Now tracking toward $1.8B Risk of all–cause death single Size:One Pack

Risk of all–cause death and pancreatic events following GLP-1 RA initiation in people with obesity or type 2 diabetes: observations from a federated research network - PMC

People with type 1 diabetes are already using GLP-1 medications, but larger studies verifying that these drugs are safe for weight loss and glucose management in this group are necessary

single

Size:One Pack

The Clinical Bottom Line: Do Not Stop the Drug Because Weight Loss Is Modest When a patient returns at six months having lost only eight pounds, the instinct for both patient and physician is to question whether the medication is working